These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 36831317)

  • 1. Peroxisome Proliferator-Activated Receptor-Targeted Therapies: Challenges upon Infectious Diseases.
    Kim IS; Silwal P; Jo EK
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.
    Latruffe N; Vamecq J
    Biochimie; 1997; 79(2-3):81-94. PubMed ID: 9209701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
    Bocher V; Chinetti G; Fruchart JC; Staels B
    J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease.
    Guan Y
    Minerva Urol Nefrol; 2002 Jun; 54(2):65-79. PubMed ID: 12185990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptors, coactivators, and downstream targets.
    Qi C; Zhu Y; Reddy JK
    Cell Biochem Biophys; 2000; 32 Spring():187-204. PubMed ID: 11330046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.
    Schoonjans K; Staels B; Auwerx J
    Biochim Biophys Acta; 1996 Jul; 1302(2):93-109. PubMed ID: 8695669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer.
    Wagner N; Wagner KD
    Cells; 2022 Aug; 11(15):. PubMed ID: 35954274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlocking new avenues for neuropsychiatric disease therapy: the emerging potential of Peroxisome proliferator-activated receptors as promising therapeutic targets.
    Dey AD; Mannan A; Dhiman S; Singh TG
    Psychopharmacology (Berl); 2024 Aug; 241(8):1491-1516. PubMed ID: 38801530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
    Chinetti G; Fruchart JC; Staels B
    Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.
    Chinetti G; Fruchart JC; Staels B
    Z Kardiol; 2001; 90 Suppl 3():125-32. PubMed ID: 11374025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting PPARs for therapy of atherosclerosis: A review.
    Miao M; Wang X; Liu T; Li YJ; Yu WQ; Yang TM; Guo SD
    Int J Biol Macromol; 2023 Jul; 242(Pt 2):125008. PubMed ID: 37217063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of peroxisome proliferator-activated receptor fate by the ubiquitinproteasome system.
    Genini D; Catapano CV
    J Recept Signal Transduct Res; 2006; 26(5-6):679-92. PubMed ID: 17118805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPAR: a mediator of peroxisome proliferator action.
    Green S
    Mutat Res; 1995 Dec; 333(1-2):101-9. PubMed ID: 8538617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology and therapeutic applications of peroxisome proliferator- activated receptors.
    Menendez-Gutierrez MP; Roszer T; Ricote M
    Curr Top Med Chem; 2012; 12(6):548-84. PubMed ID: 22242855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease.
    Guan Y; Breyer MD
    Kidney Int; 2001 Jul; 60(1):14-30. PubMed ID: 11422732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.
    Peyrou M; Ramadori P; Bourgoin L; Foti M
    PPAR Res; 2012; 2012():757803. PubMed ID: 23024649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Regulation of PPARs through Post-Translational Modifications.
    Brunmeir R; Xu F
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptors as therapeutic target for cancer.
    Wang Y; Lei F; Lin Y; Han Y; Yang L; Tan H
    J Cell Mol Med; 2024 Mar; 28(5):e17931. PubMed ID: 37700501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men.
    Rigamonti E; Chinetti-Gbaguidi G; Staels B
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1050-9. PubMed ID: 18323516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARs as Nuclear Receptors for Nutrient and Energy Metabolism.
    Hong F; Pan S; Guo Y; Xu P; Zhai Y
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31336903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.